Search research articles
Contact Us
Filters
Showing results (41-50 of 133) with videos related to
Page
of 14
Sort By:
AIDS (London, England)
|
June 16, 2001
Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
E Bernasconi, M Uhr, L Magenta, et al.
AIDS Research and Human Retroviruses
|
August 25, 2000
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors
F Bally, R Martinez, S Peters, et al.
Journal of Clinical Microbiology
|
February 1, 1995
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness
C Guerrero, C Bernasconi, D Burki, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1993
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis
A Telenti, P Imboden, F Marchesi, et al.
Lancet (London, England)
|
July 6, 2000
Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study
H Furrer, M Opravil, E Bernasconi, et al.
AIDS (London, England)
|
January 5, 2002
Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient
G Greub, A Maziéro, P Bürgisser, et al.
The Journal of Infectious Diseases
|
October 1, 1990
Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy
A Telenti, A J Aksamit, J Proper, et al.
Dermatology (Basel, Switzerland)
|
September 18, 1999
The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors
M Monod, M Borg-von Zepelin, A Telenti, et al.
Journal of Virology
|
March 10, 2001
Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1
G Bleiber, M Munoz, A Ciuffi, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
May 8, 2000
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction
C Marzolini, A Telenti, T Buclin, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 133) with videos related to
Sort By:
Page
of 14
AIDS (London, England)
|
June 16, 2001
Homocysteinaemia in HIV-infected patients treated with highly active antiretroviral therapy
E Bernasconi, M Uhr, L Magenta, et al.
AIDS Research and Human Retroviruses
|
August 25, 2000
Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors
F Bally, R Martinez, S Peters, et al.
Journal of Clinical Microbiology
|
February 1, 1995
A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness
C Guerrero, C Bernasconi, D Burki, et al.
Antimicrobial Agents and Chemotherapy
|
October 1, 1993
Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis
A Telenti, P Imboden, F Marchesi, et al.
Lancet (London, England)
|
July 6, 2000
Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study
H Furrer, M Opravil, E Bernasconi, et al.
AIDS (London, England)
|
January 5, 2002
Spare post-exposure prophylaxis with round-the-clock HIV testing of the source patient
G Greub, A Maziéro, P Bürgisser, et al.
The Journal of Infectious Diseases
|
October 1, 1990
Detection of JC virus DNA by polymerase chain reaction in patients with progressive multifocal leukoencephalopathy
A Telenti, A J Aksamit, J Proper, et al.
Dermatology (Basel, Switzerland)
|
September 18, 1999
The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors
M Monod, M Borg-von Zepelin, A Telenti, et al.
Journal of Virology
|
March 10, 2001
Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1
G Bleiber, M Munoz, A Ciuffi, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
May 8, 2000
Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction
C Marzolini, A Telenti, T Buclin, et al.
Page
of 14